PRN: Elsevier Offers Gold Standard Drug Database API as Web-Accessible, Cloud-Hosted Solution
Elsevier Offers Gold Standard Drug Database API as Web-Accessible, Cloud-Hosted Solution [08-March-2016] PHILADELPHIA, March 8, 2016 /PRNewswire/ --  Provides daily updated drug information to ensure patient safety; optional cloud delivery for a more versatile, forward-thinking drug database Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it is now offering its Gold Standard Drug Database (GSDD) Application Program Interface (API) in the Elsevier cloud powered by Amazon Web Services.
08/mar/2016 10:43:38 PR Newswire Turismo Contatta l'autore
Elsevier Offers Gold Standard Drug Database API as Web-Accessible, Cloud-Hosted Solution |
[08-March-2016] |
PHILADELPHIA, March 8, 2016 /PRNewswire/ --  Provides daily updated drug information to ensure patient safety; optional cloud delivery for a more versatile, forward-thinking drug database Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it is now offering its Gold Standard Drug Database (GSDD) Application Program Interface (API) in the Elsevier cloud powered by Amazon Web Services. This new optional delivery method will make it easier for clients to receive and integrate data feeds, thereby saving time and resources, people and hardware. Benefits of the web-accessible, cloud-hosted GSDD solution suite include:
Karthik Krishnan, Senior Vice President, Clinical Reference & Workflow, Elsevier Clinical Solutions, said that offering the GSDD database in the Elsevier cloud provides significant benefits to the client, including the flexibility to connect (API) with existing business systems. "With less time needed to focus on technology and more time available to run their business, clients will be able to take advantage of the daily updates," Krishnan said. "And the new API can significantly improve business ROI." The new cloud-hosted web API joins Elsevier's existing GSDD delivery options in technological superiority among drug databases. Features unique to GSDD include:
"With this new offering, Elsevier is responding to a market need for customers who no longer want to focus their efforts on making technology work and shift their focus to driving their pharmacy business forward. The APIs provide the customers an opportunity to easily integrate with other business systems and scale their workflow in ways not possible for," added Krishnan. Elsevier's GSDD is the next-generation drug database and drug decision support engine, fulfilling complex and evolving drug information needs throughout the healthcare system. GSDD enables healthcare professionals to quickly make fully informed decisions on drug prescribing, dispensing, adjudication and analysis. GSDD delivers the most current, accurate and relevant drug data with TRUE Daily Updatesâ¢, eliminating alert fatigue and delivering appropriate answers according to the healthcare setting. For additional information, visit http://www.goldstandard.com. About Elsevier  Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic ! reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. http://www.elsevier.com |